- Home
- AUTL vs CYH Comparison
AUTL vs CYH Comparison
Compare AUTL & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- CYH
- Stock Information
- Founded
- AUTL 2014
- CYH 1985
- Country
- AUTL United Kingdom
- CYH United States
- Employees
- AUTL N/A
- CYH N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- CYH Hospital/Nursing Management
- Sector
- AUTL Health Care
- CYH Health Care
- Exchange
- AUTL Nasdaq
- CYH Nasdaq
- Market Cap
- AUTL 360.6M
- CYH 362.0M
- IPO Year
- AUTL 2018
- CYH 1991
- Fundamental
- Price
- AUTL $1.51
- CYH $2.43
- Analyst Decision
- AUTL Strong Buy
- CYH Hold
- Analyst Count
- AUTL 5
- CYH 8
- Target Price
- AUTL $9.32
- CYH $4.02
- AVG Volume (30 Days)
- AUTL 2.0M
- CYH 2.5M
- Earning Date
- AUTL 05-08-2025
- CYH 04-23-2025
- Dividend Yield
- AUTL N/A
- CYH N/A
- EPS Growth
- AUTL N/A
- CYH N/A
- EPS
- AUTL N/A
- CYH N/A
- Revenue
- AUTL $10,120,000.00
- CYH $12,634,000,000.00
- Revenue This Year
- AUTL $277.74
- CYH N/A
- Revenue Next Year
- AUTL $221.89
- CYH $4.16
- P/E Ratio
- AUTL N/A
- CYH N/A
- Revenue Growth
- AUTL 496.00
- CYH 1.15
- 52 Week Low
- AUTL $1.11
- CYH $2.24
- 52 Week High
- AUTL $5.00
- CYH $6.29
- Technical
- Relative Strength Index (RSI)
- AUTL 49.38
- CYH 40.21
- Support Level
- AUTL $1.32
- CYH $2.26
- Resistance Level
- AUTL $1.45
- CYH $2.60
- Average True Range (ATR)
- AUTL 0.16
- CYH 0.19
- MACD
- AUTL 0.04
- CYH 0.01
- Stochastic Oscillator
- AUTL 65.85
- CYH 43.02
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.